Abstract

Objective: To review existing clinical trials in humans having Unani Regimenal Therapy for the management of insomnia. Data sources: A systematic review was conducted using PubMed, Google Scholar, and Google from January 2010 to March 2024. Study selection: Keywords like “Insomnia, Sehar, Sahar, Bekhawbi” and “Ilaj bil Tadbeer, Unani Medicine, Greco-Arab Medicine” were used in the search strategy. Only studies in English were selected. Two reviewers independently screened the studies, and conflicts were resolved by consensus. Studies that do not list the Unani Regimenal Therapy were excluded. Data extraction: A total of 22 articles were identified, and 7 were included in the final analysis. The following data were extracted: author, year of publication, intervention, outcome measures, and result. Data synthesis: The results of the present review indicate that the implication of Unani Regimenal Therapy positively is beneficial in the management of insomnia. Conclusion: Insomnia, resembling Sahar in Unani medicine, is typically treated with drugs in conventional medicine, often with adverse effects. However, the reviewed studies reveal the efficacy and safety of Unani Regimenal Therapy in alleviating insomnia symptoms without adverse effects. Early intervention with this therapy yields better outcomes, but more clinical trials are needed due to limited research. While some Regimenal Therapy modalities like Naṭūl (Irrigation Therapy), Tadhīn (Oiling), and Dalk (Therapeutic Massage) are explored, others remain unexplored. Overall, combining medicine with Unani Regimenal Therapy offers a promising approach to managing insomnia.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.